Navigation Links
Bipolar Coaxial 6495

ProductsBipolar Coaxial 6495
Company Medtronic Inc.
Item Bipolar Coaxial 6495
Features Coaxial lead body for excellent electrical performance. Slimmer curved myocardial needle to minimize tissue perforation. Two discrete electrodes are optimally spaced for consistent pacing and sensing. Proximal electrode is swaged for smoother transition through tissue. Relaxed fixation coil minimizes tissue trauma while securely positioning electrode. Connector pin sleeves insulate connector pins while not in use.
Description The Medtronic Model 6495 bipolar coaxial temporary pacing lead is designed to provide the advantages of bipolar technology based on the sensing and pacing capabilities of the Medtronic Model 6500 unipolar temporary pacing lead.
Info Medtronic Inc.
Customer Service: (800) 551-5544
Web site: http://www.medtronic.com/

Related medicine products :

1. Disposable Bipolar Pencil - 18 Gauge Curved
2. Disposable Bipolar Pencil - 18 Gauge Straight
3. Disposable Bipolar Pencil - 23 Gauge Tapered Tip
4. McPherson Straight Bipolar Forceps
5. McCullough Bipolar Forceps
6. Bipolar Coaptation Forceps
7. Jeweler Type Bipolar Insulated Forceps
8. Cozean Bipolar Forceps
9. Tenzel Bipolar Forceps
10. Shepard Bipolar Forceps Angled
11. Osher Bipolar Coaptation Forceps
Breaking Medicine Technology:ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Lack of happiness hormone serotonin in the brain causes impaired maternal behavior in mice 8972 1Energy saving method checks refrigerant level in air conditioners 8970 1Energy saving method checks refrigerant level in air conditioners 8970 2How to text message and avoid pain 8968 1How to text message and avoid pain 8968 2